| scholarly article | Q13442814 |
| P50 | author | Peter Höglund | Q40045887 |
| P2093 | author name string | Sven Björkman | |
| Tord Juhlin | |||
| P2860 | cites work | Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease | Q28192992 |
| Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin | Q28196727 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. | Q33895894 | ||
| Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure? | Q33926765 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Influence of progressive renal dysfunction in chronic heart failure | Q34604651 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). | Q34682919 | ||
| A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group | Q34718800 | ||
| Is aspirin safe for patients with heart failure? | Q36823330 | ||
| Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) | Q40906958 | ||
| Effect of vasoactive peptides on prostacyclin synthesis in man. | Q41776050 | ||
| The prognostic importance of different definitions of worsening renal function in congestive heart failure | Q44078844 | ||
| NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. | Q50885532 | ||
| Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. | Q50908731 | ||
| Renal function, neurohormonal activation, and survival in patients with chronic heart failure. | Q52076638 | ||
| Angiotensin-converting enzyme inhibitors and renal function in heart failure | Q54260089 | ||
| Peripheral hemodynamic effects of captopril in patients with congestive heart failure. | Q54365198 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1049-1056 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors | |
| P478 | volume | 7 |
| Q38038881 | A review of the efficacy, safety, and cost-effectiveness of COX-2 inhibitors for Africa and the Middle East region |
| Q43423190 | Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis |
| Q51063523 | Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients. |
| Q36593651 | Effect of pravastatin and fosinopril on recurrent urinary tract infections |
| Q37703574 | Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults |
| Q49826328 | Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population |
| Q34975871 | Reducing Adverse Self-Medication Behaviors in Older Adults with Hypertension: Results of an e-health Clinical Efficacy Trial |
| Q46365651 | Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. |
| Q37178937 | Review of the cardiovascular safety of COXIBs compared to NSAIDS. |
| Q50072927 | Study of drug-Drug interactions among the hypertensive patients in a tertiary care teaching hospital |
| Q33790527 | The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study |
| Q34853781 | The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. |
| Q38316845 | The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspective |
| Q33737469 | The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. |
| Q48277925 | Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort |
Search more.